Weaver C. Barksdale & Associates’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-50
Closed -$5K 568
2014
Q4
$5K Sell
50
-26
-34% -$2.02K ﹤0.01% 399
2014
Q3
$5K Buy
76
+7
+10% +$460 ﹤0.01% 394
2014
Q2
$5K Buy
69
+11
+19% +$748 ﹤0.01% 401
2014
Q1
$4K Sell
58
-7
-11% -$522 ﹤0.01% 432
2013
Q4
$4K Sell
65
-721
-92% -$46.7K ﹤0.01% 429
2013
Q3
$50K Buy
+786
New +$47.5K 0.05% 135

Weaver C. Barksdale & Associates's CBST Position: Q1 2015 in Review

Weaver C. Barksdale & Associates sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 50 shares — an estimated $5K sold.

Weaver C. Barksdale & Associates first reported a position in CBST in Q3 2013 and held it in 6 quarters. The position peaked at $50K in Q3 2013. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Weaver C. Barksdale & Associates reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Weaver C. Barksdale & Associates sold 50 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $5K.
  • Weaver C. Barksdale & Associates first reported a position in CUBIST PHARMACEUTICALS INC in Q3 2013 and held it in 6 quarters.
  • Weaver C. Barksdale & Associates's CUBIST PHARMACEUTICALS INC position peaked at $50K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Weaver C. Barksdale & Associates's 13F filing for Q1 2015, filed 9 Apr 2015.